Dr. Grey AI

Bone Health

Bone health refers to the strength of bones and the quality of bone structure. Bone health is usually measured as bone mineral density. Bone health is affected by nutrient intake, hormonal regulation, exercise, and age, among other factors.

Quick Answer

What it is

Bone health refers to the strength of bones and the quality of bone structure. Bone health is usually measured as bone mineral density.

Key findings

  • Grade A: Osteocalcin Carboxylation (Vitamin K2 (MK-7))
  • Grade A: Fracture Risk (Strontium)
  • Grade A: Bone Formation Markers (Romosozumab (Evenity))

Safety

No specific caution or interaction language was detected in the current summary/outcome notes.

ℹ️ Quick Facts

Quick Facts: Bone Health

  • Supplements Studied:34
  • Research Trials:38
  • Total Participants:106,923
  • Grade A Supplements:2
  • Top Supplement:Strontium (A)
38 trials
106,923 ppts
34 supps · 82 outcomes

Evidence-Based Protocol

Supplement stack ranked by research quality

Moderate Evidence

Primary Stack (Tier 1)

Soy IsoflavonesB
200g daily

Selectively activates estrogen receptor-beta to maintain bone mineral density

172 studies | 21,252 participants
Vitamin KB
10mg daily

Activates osteocalcin protein required for calcium binding to bone matrix

60 studies | 28,116 participants
CurcuminB
500mg daily

Inhibits osteoclast differentiation via NF-ÎşB pathway suppression

84 studies | 3,526 participants
resistance-trainingB
3 sessions weekly

Supports bone health through multiple complementary pathways

29 studies | 1,075 participants

Supporting Stack (Tier 2)

Vitamin DC
10mcg daily

Enhances intestinal calcium absorption and regulates osteoblast/osteoclast balance

30 studies | 84,996 participants
Coleus forskohliiC
250mg daily

Supports bone health through multiple complementary pathways

10 studies | 300 participants
Vitamin CC
45mg daily

Supports bone health through multiple complementary pathways

6 studies | 428 participants
MagnesiumC
30mg daily

Supports bone health through multiple complementary pathways

6 studies | 180 participants

How It Works

This supplement protocol targets calcium-vitamin D homeostasis, which plays a central role in bone mineral density and skeletal strength. When this pathway functions optimally, the body maintains better bone health outcomes through improved cellular signaling and reduced physiological stress. Bone health depends on a delicate balance between bone-building osteoblasts and bone-resorbing osteoclasts, with proper mineral delivery and hormonal signaling.

Soy Isoflavones serves as the foundation of this protocol. It selectively activates estrogen receptor-beta to maintain bone mineral density. Vitamin K complements this approach by activates osteocalcin protein required for calcium binding to bone matrix. Curcumin complements this approach by inhibits osteoclast differentiation via nf-Îşb pathway suppression. resistance-training complements this approach by supports bone health through multiple complementary pathways.

Good clinical evidence supports this combination approach. By addressing multiple points along the calcium-vitamin pathway, these supplements work synergistically to produce better results than any single intervention alone. The combined effect helps restore balance to systems that become dysregulated in bone health.

Rather than masking symptoms like conventional medications, these natural compounds support your body's intrinsic healing mechanisms and regulatory systems.

Initial improvements may be noticed within 4-6 weeks, with continued benefits developing over 2-3 months. Consistency is key. For best results, take with meals to enhance absorption unless otherwise directed and maintain regular daily use.

Generated from peer-reviewed researchSchema v

Supplements for Bone Health

Sorted by strength of evidence

AStrontium
3
↑Fracture RiskWorsens↑Bone Mineral DensityImproves↑Bone MicroarchitectureImproves
AVitamin K2 (MK-7)
1
↑Osteocalcin CarboxylationImproves↑Bone Mineral Density (Lumbar)Improves↑Bone Mineral Density (Femoral Neck)Improves
BHydroxyapatite
2
↑Bone Mineral DensityImproves↓Corticosteroid-Induced Bone LossImproves
BSoy Isoflavones
1
↑Bone Mineral DensityImproves↑Bone turnover markersWorsens
BVitamin K
1
↑Bone Mineral DensityImprovesC-Reactive Protein (CRP)↑Fracture RiskWorsens
BManganese
1
↑Bone Mineral DensityImproves↑Bone Formation MarkersImproves
BCurcumin
1
↓Blood glucoseImproves↓Body Mass Index (BMI)Improves↓Heart RateImproves
BCopper
1
↑Bone Mineral DensityImproves↓Bone Turnover MarkersImproves
CPhosphorus
2
↑Bone MineralizationImproves↓Bone Mineral Density (Excess Intake)Worsens
CColeus forskohlii
1
↓Body FatImproves↑Bone Mineral DensityImproves↑Muscle MassImproves
CVitamin C
1
↑Anti-Oxidant Enzyme ProfileImproves↑Bone Mineral DensityImproves
CVitamin D
1
↓Bone turnover markersImproves↑Fracture RiskWorsens↑Calcium AbsorptionImproves
CHorny Goat Weed
1
↑Bone Mineral DensityImproves↑EstrogenWorsens
CMagnesium
1
↑Bone Mineral DensityImproves↑OsteocalcinImproves
CButea Monosperma
1
↑Bone Mineral DensityImproves
CCitric Acid
1
↓Bone ResorptionImproves
CElectrolytes
1
↑Bone Mineral MetabolismImproves
CLactosucrose
1
↑Calcium AbsorptionImproves
CLongan
1
↑Bone HealthImproves
CSilica
1
↑Bone Mineral DensityImproves

Detailed Outcomes

Grade:
Effect:
Size:
Sort:
|
A
Osteocalcin Carboxylation
50% reduction in ucOC at 180 mcg/day
6 studies
large↑Improves
B
Bone Mineral Density (Lumbar)
Significantly decreased age-related BMD decline
4 studies
moderate↑Improves
B
Bone Mineral Density (Femoral Neck)
Reduced bone loss vs placebo
3 studies
moderate↑Improves
B
Bone Strength
Improved femoral neck strength after 3 years
2 studies
moderate↑Improves
C
Trabecular Bone Microarchitecture
Prevented age-related deterioration at tibia
2 studies
moderate↑Improves
A
Fracture Risk
Multiple large RCTs (SOTI, TROPOS) demonstrated strontium ranelate reduced vertebral fractures by ~40% and non-vertebral fractures in postmenopausal women with osteoporosis. This applies only to the prescription ranelate form, which was restricted in Europe in 2014 due to cardiovascular safety concerns; OTC strontium citrate has not been tested for fracture endpoints.
5 studies
moderate↑Worsens
B
Bone Mineral Density
RCTs of strontium ranelate showed significant increases in DEXA-measured bone mineral density in postmenopausal women. However, 10-15% of the measured increase is artifact due to strontium's higher atomic mass inflating DEXA readings. An animal study (PMID:38612883) comparing ranelate, citrate, and chloride forms in ovariectomized mice found all forms improved bone mineral density.
4 studies
moderate↑Improves
D
Bone Microarchitecture
A comparative animal study (PMID:38612883) in ovariectomized female mice found that strontium ranelate, citrate, and chloride all improved bone morphology and microarchitecture, suggesting potential benefits across strontium forms in preclinical models. Human data for non-ranelate forms is lacking.
1 study
moderate↑Improves
A
Bone Formation Markers
Romosozumab rapidly increases bone formation markers (P1NP) with peak at 2 weeks, demonstrating its anabolic effect.
large↑Improves
A
Bone Resorption Markers
Romosozumab reduces bone resorption markers (CTX), demonstrating its unique dual mechanism of action.
moderate↓Improves
A
Bone Turnover Markers
Rapid and sustained reduction in bone resorption markers (CTX) within days of administration.
large↓Improves
A
Bone Formation Markers
Teriparatide rapidly increases bone formation markers (P1NP, osteocalcin) within weeks of treatment initiation.
large↑Improves
A
Bone Turnover Markers
Calcitonin reduces bone resorption markers through direct inhibition of osteoclast activity.
moderate↓Improves
A
Hypercalcemia
Calcitonin is FDA-approved for acute treatment of hypercalcemia, rapidly lowering serum calcium through inhibition of bone resorption.
large↓Improves
B
Chronic Bone Pain
Calcitonin provides pain relief in osteoporosis and other painful bone conditions through central and peripheral analgesic mechanisms.
moderate↓Improves
A
Height Velocity (Children)
Sermorelin induced catch-up growth in GH-deficient children with significant increases in height velocity sustained during 12 months of treatment, with effects maintained for up to 36 months.
large↑Improves
B
Bone Mineral Density
Moderate Improvement
63 studies
moderate↑Improves
?
Bone turnover markers
23 studies
↑Worsens
B
Bone Mineral Density
Moderate Improvement
13 studies
moderate↑Improves
D
C-Reactive Protein (CRP)
No effect
1 study
none
?
Fracture Risk
12 studies
↑Worsens
?
Weight
2 studies
↓Improves
?
Interleukin 6
1 study
↓Improves
?
Osteoprotegerin
1 study
↑Improves
B
Bone Mineral Density
A meta-analysis of 6 RCTs (n=614) found ossein-hydroxyapatite complex (OHC) preserved +1.02% more BMD than calcium carbonate. The largest comparative study (n=851 perimenopausal women, 3 years) showed OHC maintained stable lumbar BMD while calcium carbonate lost 3.1% (p<0.001), despite the OHC group receiving less elemental calcium (712 vs 1000 mg/day). Additional RCTs in postmenopausal, surgically menopausal, and senile osteoporosis populations consistently favor OHC over calcium carbonate for BMD preservation.
9 studies
small↑Improves
C
Corticosteroid-Induced Bone Loss
Two controlled trials in corticosteroid-treated patients found MCHC attenuated bone loss. Stellon et al. (1985) showed MCHC halted bone mineral content loss in 36 patients with chronic active hepatitis on corticosteroids over 2 years (p<0.025 for cortical thickness). Pines et al. (1984) found MCHC (6-8 g/day) significantly reduced bone pain (p<0.001) and slowed cortical bone loss in 40 patients on long-term prednisolone.
2 studies
small↓Improves
B
Blood glucose
Small Improvement
6 studies
small↓Improves
?
Body Mass Index (BMI)
6 studies
↓Improves
?
Heart Rate
6 studies
↓Improves
?
Oxygen Uptake
6 studies
↑Improves
?
Bone Mineral Density
5 studies
↑Improves
?
Total Antioxidant Capacity (TAC)
5 studies
↑Improves
?
Bone-specific Alkaline Phosphatase
4 studies
↑Improves
?
C-Reactive Protein (CRP)
4 studies
↓Improves
B
Bone Mineral Density
Small Increase
5 studies
small↑Improves
B
Bone Formation Markers
Moderate Increase
4 studies
moderate↑Improves
B
Bone Mineral Density
Small Increase
4 studies
small↑Improves
C
Bone Turnover Markers
Small Decrease
3 studies
small↓Improves
B
Longitudinal Bone Growth
In animal studies, ipamorelin dose-dependently increased longitudinal bone growth rate from 42 ÎĽm/day to 52 ÎĽm/day, with pronounced effects on body weight gain.
moderate↑Improves
B
Bone Mineral Content
12-week treatment with ipamorelin increased total tibial and vertebral bone mineral content in adult rats, primarily through increased bone dimensions rather than volumetric density.
moderate↑Improves
B
Glucocorticoid-Induced Bone Loss
Ipamorelin counteracted glucocorticoid-induced decreases in bone formation, with periosteal bone formation rate increasing four-fold when combined with glucocorticoids.
moderate↓Improves
C
Bone Resorption
Limited human trials suggest alkali citrate supplementation may modestly reduce bone resorption markers and urinary calcium loss, particularly in postmenopausal women. The mechanism relates to systemic acid-base balance correction rather than direct bone effects, and clinical significance for fracture prevention remains unclear.
4 studies
small↓Improves
C
Bone Mineral Metabolism
Animal and human studies show that electrolyte balance—particularly calcium, magnesium, and the acid-base effects of potassium bicarbonate—influences urinary mineral excretion and bone mineral retention. Alkaline potassium salts may reduce urinary calcium loss, though direct bone density outcomes from combined electrolyte supplementation are limited.
4 studies
small↑Improves
C
Bone Mineralization
Phosphorus is essential for hydroxyapatite crystal formation in bone. An RCT found phosphate and carbonate salts of calcium supported robust bone building in osteoporosis. However, adequate calcium co-intake is required; phosphorus supplementation without sufficient calcium may paradoxically impair bone health by stimulating PTH secretion.
4 studies
moderate↑Improves
C
Bone Mineral Density (Excess Intake)
Observational studies associate excessive phosphorus intake (particularly phosphoric acid from soft drinks) with lower bone mineral density. The mechanism involves chronic PTH elevation from high phosphorus-to-calcium ratio, leading to increased bone resorption. This effect is most pronounced when calcium intake is inadequate relative to phosphorus.
3 studies
small↓Worsens
C
Bone Mineral Density
Population-based epidemiological studies (including Framingham cohort data) link higher dietary silicon intake with better bone mineral density, particularly in premenopausal women. One RCT in osteopenic women showed improvement in bone formation markers with ch-OSA added to calcium/vitamin D supplementation versus calcium/vitamin D alone.
4 studies
small↑Improves
C
Bone Mineral Density
In vitro studies show cajanin (10nM) and medicarpin (6nM) promote osteoblast differentiation and mineralization with potency comparable to or exceeding 17β-estradiol. In ovariectomized rat models of postmenopausal osteoporosis, these compounds preserved bone mineral density and improved bone microarchitecture. Medicarpin acts through non-estrogenic mechanisms, potentially allowing bone benefits without hormonal side effects.
3 studies
moderate↑Improves
C
Bone Health
A 12-week double-blind RCT in 50 elderly participants found longan pulp and seed extract significantly reduced alkaline phosphatase levels versus placebo (mean difference -7.06 U/L, p=0.023), though other bone turnover markers did not reach significance. In vitro studies show longan fruit extract stimulates osteoblast differentiation via Erk1/2-dependent RUNX2 activation.
2 studies
small↑Improves
C
Body Fat
Small Decrease
1 study
small↓Improves
?
Bone Mineral Density
1 study
↑Improves
?
Muscle Mass
1 study
↑Improves
?
Testosterone
1 study
↑Improves
?
Weight
1 study
↓Improves
C
Anti-Oxidant Enzyme Profile
Small Increase
1 study
small↑Improves
?
Bone Mineral Density
2 studies
↑Improves
C
Bone turnover markers
Small Improvement
1 study
small↓Improves
?
Fracture Risk
12 studies
↑Worsens
?
Calcium Absorption
1 study
↑Improves
?
Parathyroid Hormone
1 study
↑Improves
C
Bone Mineral Density
Small Improvement
1 study
small↑Improves
?
Estrogen
1 study
↑Worsens
C
Bone Mineral Density
Small Improvement
1 study
small↑Improves
?
Osteocalcin
2 studies
↑Improves
C
Calcium Absorption
A single-blind, randomized, placebo-controlled 96-week trial in 17 healthy young women found that 12 g/day lactosucrose significantly reduced fecal calcium excretion and increased apparent calcium absorption and retention compared to placebo. Magnesium and phosphorus absorption were also improved. Effects were maintained throughout the long treatment period.
1 study
small↑Improves
D
Bone Mineral Density
In vitro studies show osthole stimulates osteoblast differentiation and bone formation. Animal models of osteoporosis suggest inhibition of osteoclast activity and improved bone density. No human data exists.
5 studies
small↑Improves
D
Bone Mineral Density
No effect
4 studies
none
?
Osteocalcin
1 study
↑Improves
?
Weight
1 study
↓Improves
D
Bone Mineral Density
No effect
3 studies
none
?
IGF-1
3 studies
↑Improves
?
Estrogen
2 studies
↑Worsens
?
Free Testosterone
1 study
↑Improves
?
Testosterone
1 study
↑Improves
D
Bone Mineral Density
A review of preclinical evidence (PMID:25109459) identifies Salvia miltiorrhiza as a source of compounds with anti-osteoporotic potential in animal models. One clinical study using point injection of red sage root extract reported improved hip joint function in patients with ischemic femoral head necrosis (PMID:19526810). Oral supplementation data in humans is lacking.
3 studies
small↑Improves
D
Bone Density
In ovariectomy-induced osteoporosis models, 7,8-DHF modulated bone formation and resorption and ameliorated bone loss, including via PI3K/AKT/NRF2 pathway in BMSCs. However, one study found 7,8-DHF impaired fracture healing in mice, suggesting context-dependent effects on bone metabolism.
3 studies
small↑Improves
D
Bone Health
In vitro and animal studies show myricetin induces osteoblast differentiation through the BMP-2/p38 MAPK pathway and may inhibit osteoclast-mediated bone resorption. Preclinical models suggest anti-osteoporotic effects, but no human clinical trials have been conducted.
3 studies
moderate↑Improves
D
Bone turnover markers
No effect
2 studies
none
?
Bone-specific Alkaline Phosphatase
2 studies
↑Improves
D
Bone Mineral Density
No effect
2 studies
none
?
Calcium Excretion
7 studies
↑Improves
?
Bone turnover markers
4 studies
↑Worsens
?
Net Acid Excretion
4 studies
↑Improves
D
Bone Density
In ovariectomized rats (a model of postmenopausal osteoporosis), a dong quai-containing formula (dang-gui-ji-hwang-yeum) improved bone density markers. A review of traditional Chinese medicines also identified dong quai components as having roles in osteogenesis and angiogenesis in preclinical models. No human clinical trial data exists for bone outcomes.
2 studies
small↑Improves
D
Blood glucose
No effect
1 study
none
?
Body Fat
1 study
↓Improves
?
Insulin
1 study
↑Worsens
D
Serum Calcium
No effect
1 study
none
?
Serum Magnesium
1 study
↑Improves
D
Bone Mineral Density
No effect
1 study
none
?
Muscle Mass
1 study
↑Improves
D
Bone Preservation
A single preclinical study found clove extract rich in eugenol and eugenol derivatives showed bone-preserving efficacy in an animal model of bone loss. The mechanism may involve antioxidant and anti-resorptive properties. No human clinical trials.
1 study
small↑Improves
D
Bone Mineral Density
One preclinical study reported that cyanidin-3-O-β-D-glucoside improved bone indices. No human evidence or replication studies available.
1 study
small↑Improves
D
Bone Mineral Density
In a rat model, the ratio of n-6 to n-3 essential fatty acids significantly affected calcium balance and bone parameters, with lower n-6/n-3 ratios associated with improved calcium absorption and bone mineral content.
1 study
small↑Improves
D
Bone Resorption
In vitro, scopoletin and scopolin (coumarins isolated from A. iwayomogi) suppressed RANKL-induced osteoclast differentiation in RAW 264.7 macrophage cells by scavenging intracellular ROS and superoxide anions during osteoclastogenesis. Single in vitro study with no animal or human follow-up.
1 study
small↓Improves
D
Bone Mineralization / Collagen Production
An in vitro study found calcium threonate enhanced mineralized nodule formation and collagenous protein production in cultured cells over 5 weeks. Collagenous proteins accounted for 85% of the increase in total protein. No in vivo confirmation exists.
1 study
small↑Improves
D
Bone Health
An in vitro study (Yu 2012) showed D-chiro-inositol, pinitol's active metabolite, dose-dependently inhibited RANKL-induced osteoclast differentiation by downregulating NFATc1 transcription factor. No animal or human studies have examined pinitol directly for bone outcomes.
1 study
small↑Improves
D
Bone Health
In 75 aged laying hens, dietary supplementation with Îł-PGA combined with nanosized zinc oxide increased eggshell thickness and elevated serum mineral concentrations compared to conventional supplementation. Separately, the compound's known calcium-binding properties suggest potential for enhancing calcium absorption, though direct human evidence is lacking.
1 study
small↑Improves
?
Bone Mineral Density
14 studies
↑Improves
?
Bone Mineral Density
5 studies
↑Improves
?
Bone Mineral Density
4 studies
↑Improves
?
Bone Mineral Density
4 studies
↑Improves
?
Bone-specific Alkaline Phosphatase
1 study
↑Improves
?
Bone Mineral Density
1 study
↑Improves
?
Hyperthyroidism Symptoms
1 study
↓Improves
?
CTX-II
1 study
↑Improves
?
Fracture Healing
1 study
↑Improves
?
Bone Mineral Density
1 study
↑Improves

Related Conditions

Metabolic Health

21 shared supplements · 975 outcomes

Research on metabolism, blood glucose regulation, insulin sensitivity, and metabolic syndrome.

Body Composition

16 shared supplements · 253 outcomes

Body composition refers to the relative percentage of fat, muscle, and bone in someone’s body. Body composition is sometimes reported as fat and fat-free mass.

Menopause

15 shared supplements · 223 outcomes

Menopause is the stage of life when menses permanently cease, and the reproductive system no longer performs functions related to fertility. A woman is considered to have entered menopause after menses have stopped for 12 months.

15 shared supplements · outcomes

Type 2 Diabetes

14 shared supplements · 868 outcomes

Type 2 diabetes (T2D) is a disease in which blood glucose levels are too high. It is characterized by insulin resistance in muscle, fat, and pancreas cells and an inability of the pancreas to manufacture enough insulin to control blood glucose levels. T2D is strongly associated with excess body fat, and weight loss induced by lifestyle changes is extremely effective for treating T2D.

Weight Loss & Maintenance

13 shared supplements · 433 outcomes

This goal refers to people with a BMI &gt;25 attempting to reach/maintain their ideal weight. While interventions that work for people with a BMI &gt;25 may also work for people with a lower BMI, the context is often sufficiently different that this isn't assured.

High Cholesterol

13 shared supplements · 553 outcomes

High amounts of low-density lipoproteins cause fatty plaques to build up in the arteries, which restricts blood flow and can cause health problems like a heart attack. Lifestyle factors (e.g., poor diet, smoking) and genetics play a huge role in blood cholesterol levels.

Cardiovascular Disease

13 shared supplements · 223 outcomes

Cardiovascular disease (CVD) is a broad term that refers to various diseases of the heart and blood vessels. Atherosclerotic CVD (ASCVD) is the most common subtype of CVD and causes strokes and heart attacks.